188 related articles for article (PubMed ID: 24112130)
1. Long pentraxin PTX3 attenuates ischemia reperfusion injury in a cardiac transplantation model.
Zhu H; Cui D; Liu K; Wang L; Huang L; Li J
Transpl Int; 2014 Jan; 27(1):87-95. PubMed ID: 24112130
[TBL] [Abstract][Full Text] [Related]
2. Hmgb1-TLR4-IL-23-IL-17A axis promote ischemia-reperfusion injury in a cardiac transplantation model.
Zhu H; Li J; Wang S; Liu K; Wang L; Huang L
Transplantation; 2013 Jun; 95(12):1448-54. PubMed ID: 23677049
[TBL] [Abstract][Full Text] [Related]
3. Necrostatin-1 inhibits Hmgb1-IL-23/IL-17 pathway and attenuates cardiac ischemia reperfusion injury.
Zhang A; Mao X; Li L; Tong Y; Huang Y; Lan Y; Jiang H
Transpl Int; 2014 Oct; 27(10):1077-85. PubMed ID: 24810904
[TBL] [Abstract][Full Text] [Related]
4. Lipocalin-2 promotes m1 macrophages polarization in a mouse cardiac ischaemia-reperfusion injury model.
Cheng L; Xing H; Mao X; Li L; Li X; Li Q
Scand J Immunol; 2015 Jan; 81(1):31-8. PubMed ID: 25359467
[TBL] [Abstract][Full Text] [Related]
5. Cardio-protective effects of pentraxin 3 produced from bone marrow-derived cells against ischemia/reperfusion injury.
Shimizu T; Suzuki S; Sato A; Nakamura Y; Ikeda K; Saitoh S; Misaka S; Shishido T; Kubota I; Takeishi Y
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):306-13. PubMed ID: 26470821
[TBL] [Abstract][Full Text] [Related]
6. Netrin-1 attenuates cardiac ischemia reperfusion injury and generates alternatively activated macrophages.
Mao X; Xing H; Mao A; Jiang H; Cheng L; Liu Y; Quan X; Li L
Inflammation; 2014 Apr; 37(2):573-80. PubMed ID: 24234226
[TBL] [Abstract][Full Text] [Related]
7. Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury.
Lech M; Römmele C; Gröbmayr R; Eka Susanti H; Kulkarni OP; Wang S; Gröne HJ; Uhl B; Reichel C; Krombach F; Garlanda C; Mantovani A; Anders HJ
Kidney Int; 2013 Apr; 83(4):647-61. PubMed ID: 23325083
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction.
Salio M; Chimenti S; De Angelis N; Molla F; Maina V; Nebuloni M; Pasqualini F; Latini R; Garlanda C; Mantovani A
Circulation; 2008 Feb; 117(8):1055-64. PubMed ID: 18268142
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration.
Liao YH; Xia N; Zhou SF; Tang TT; Yan XX; Lv BJ; Nie SF; Wang J; Iwakura Y; Xiao H; Yuan J; Jevallee H; Wei F; Shi GP; Cheng X
J Am Coll Cardiol; 2012 Jan; 59(4):420-9. PubMed ID: 22261166
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-κB activation inhibitor attenuates ischemia reperfusion injury and inhibits Hmgb1 expression.
Shi Z; Lian A; Zhang F
Inflamm Res; 2014 Nov; 63(11):919-25. PubMed ID: 25209109
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of γδ T cells with macrophages.
Wang X; Sun R; Wei H; Tian Z
Hepatology; 2013 Jan; 57(1):373-84. PubMed ID: 22821628
[TBL] [Abstract][Full Text] [Related]
12. NKG2D blockade significantly attenuates ischemia-reperfusion injury in a cardiac transplantation model.
Shen B; Li J; Yang B
Transplant Proc; 2013; 45(6):2513-6. PubMed ID: 23953572
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 26a inhibits HMGB1 expression and attenuates cardiac ischemia-reperfusion injury.
Yao L; Lv X; Wang X
J Pharmacol Sci; 2016 May; 131(1):6-12. PubMed ID: 26320674
[TBL] [Abstract][Full Text] [Related]
14. The protective role of interleukin-18 binding protein in a murine model of cardiac ischemia/reperfusion injury.
Gu H; Xie M; Xu L; Zheng X; Yang Y; Lv X
Transpl Int; 2015 Dec; 28(12):1436-44. PubMed ID: 26340315
[TBL] [Abstract][Full Text] [Related]
15. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
16. Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma.
Doni A; Michela M; Bottazzi B; Peri G; Valentino S; Polentarutti N; Garlanda C; Mantovani A
J Leukoc Biol; 2006 Apr; 79(4):797-802. PubMed ID: 16461742
[TBL] [Abstract][Full Text] [Related]
17. Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications.
Cieślik P; Hrycek A
Autoimmunity; 2012 Mar; 45(2):119-28. PubMed ID: 21988562
[TBL] [Abstract][Full Text] [Related]
18. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease.
D'Angelo C; De Luca A; Zelante T; Bonifazi P; Moretti S; Giovannini G; Iannitti RG; Zagarella S; Bozza S; Campo S; Salvatori G; Romani L
J Immunol; 2009 Oct; 183(7):4609-18. PubMed ID: 19734205
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NFkappaB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion.
Yeh CH; Chen TP; Wu YC; Lin YM; Jing Lin P
J Surg Res; 2005 May; 125(1):109-16. PubMed ID: 15836859
[TBL] [Abstract][Full Text] [Related]
20. Pentraxin 3 accelerates lung injury in high tidal volume ventilation in mice.
Real JM; Spilborghs GM; Morato-Marques M; de Moura RP; Negri EM; Camargo AA; Deheinzelin D; Dias AA
Mol Immunol; 2012 May; 51(1):82-90. PubMed ID: 22425349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
